A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.

Exclusion Criteria

• •1\. Confirmed diagnosis of non-COVID19 pneumonia;
• •2\. Critically ill patients requiring mechanical ventilation, or patients who are unable to eat by mouth and swallow 3# capsules;
• •3\. Patients who had undergone gastrointestinal surgery;
• •4\. Presence of intestinal organic lesions such as congenital megacolon, intestinal obstruction, intussusception, etc.
• •5\. Pathological intestinal inflammatory changes, such as inflammatory bowel disease;
• •6\. Planned use of antacids, probiotics, antibiotics, FMT and other treatments affecting intestinal flora within the past 3 months or the following 2 months;
• •7\. Patients and their families did not agree to receive FMT treatment;
• •8\. Patients unable to cooperate with follow-up visits.